Since the 1940s, there have been conflicting theories and conclusions surrounding testosterone replacement therapy (TRT), and whether or not it is safe for hypogonadal men with or without a history of radically treated prostate cancer (PCa). This article will go over some international guidelines and recent research on how to approach TRT in hypogonadal PCa patients.
All SMSNA News
SMSNA News
SMSNA Patients
SMSNA Patients
SMSNA News
SMSNA
SMSNA News
SMSNA Patients
SMSNA
SMSNA News
SMSNA News
SMSNA Patients
SMSNA